Health Score

0 Excellent

Metadata coverage

Abstract

ORCID

References

License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder

Award / grant

Affiliation & institutional identifiers

Affiliation

ROR ID

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

Add abstracts to 22 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Low impact22 DOIs

Attach ORCID iDs across 10 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Low impact10 DOIs

Deposit reference lists for 1 record

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact1 DOIs

DOIs for this ISSN

Showing the top 5 of 136 DOIs, ordered by correction priority.

#	Title	Missing	Priority	Citations
1	Bispecific antibodies in cancer immunotherapy (10.1177/2515135518763280)	ORCID	56.85	187
2	A review of H5Nx avian influenza viruses (10.1177/2515135518821625)	ORCID	47.30	77
3	Broadly neutralizing antibodies in HIV-1 treatment and preve… (10.1177/2515135518800689)	ORCID	40.05	39
4	Vaccine hesitancy in Africa: causes and strategies to the re… (10.1177/25151355211047514)	Abstract	36.18	27
5	It is time to accelerate building local vaccine adjuvant man… (10.1177/2051013617733259)	Abstract ORCID	34.95	4
6	COVID-19 vaccine hesitancy: Pakistan struggles to vaccinate… (10.1177/25151355221077658)	Abstract	30.10	15
7	Novel tumour antigens and the development of optimal vaccine… (10.1177/2515135518768769)	ORCID	27.85	12
8	Low rate of COVID-19 vaccination in Africa: a cause for conc… (10.1177/25151355221088159)	Abstract	26.03	10
9	Healthcare-associated infections: potential for prevention t… (10.1177/2515135518763183)	ORCID	25.00	9
10	Vaccine apartheid: the separation of the world’s poorest and… (10.1177/25151355221107975)	Abstract	25.00	9
11	Improving vaccine-related health literacy in parents: compar… (10.1177/25151355211047521)	Abstract	21.13	6
12	Optimal use of meningococcal serogroup B vaccines: moving be… (10.1177/2515135518781757)	ORCID	19.45	5
13	COVID-19: should oral vaccination strategies be given more c… (10.1177/2515135520946503)	Abstract	15.05	3
14	Norovirus outbreaks and the necessity of a future NoV vaccin… (10.1177/25151355251335511)	Abstract	15.05	3
15	Routine immunization for children in the Philippines: challe… (10.1177/25151355241264528)	Abstract	11.93	2
16	Flu vaccination in the Philippines: challenges and intervent… (10.1177/25151355231213587)	Abstract	7.53	1
17	Stagnation or safety? Reassessment of the human papillomavir… (10.1177/25151355231216408)	Abstract	7.53	1
18	Media literacy: exploring the key to social media influences… (10.1177/25151355241277780)	Abstract	7.53	1
19	Pediatric asthma and COVID-19 vaccination: unveiling pattern… (10.1177/25151355241297874)	ORCID	7.53	1
20	The influence of radiation in the context of developing comb… (10.1177/2051013617750561)		0.00	14
21	The failure of radical treatments to cure cancer: can less d… (10.1177/2515135518815393)		0.00	11
22	Cancer stem cell mobilization and therapeutic targeting of t… (10.1177/2515135518821623)		0.00	15
23	Burden, effectiveness and safety of influenza vaccines in el… (10.1177/2515135519826481)		0.00	41
24	Therapeutic vaccination immunomodulation: forming the basis… (10.1177/2515135519862234)		0.00	20
25	Seasonal influenza vaccination: knowledge, attitude and prac… (10.1177/2515135519868152)		0.00	8
26	Identification of goals and barriers to treatment from 92 co… (10.1177/2515135519869763)		0.00	4
27	Alphavirus-based hepatitis C virus therapeutic vaccines: can… (10.1177/2515135519874677)		0.00	1
28	Is a universal influenza vaccine feasible? (10.1177/2515135519885547)		0.00	2
29	Insights into innate and adaptive immune responses in vaccin… (10.1177/2515135519888998)		0.00	14
30	Active surveillance of adverse events following immunization… (10.1177/2515135519889000)		0.00	15
31	Cross-reactivity with Brazilian strains of <i>Neisseria meni… (10.1177/2515135519894825)		0.00	3
32	Hepatitis B vaccine knowledge and self-reported vaccination… (10.1177/2515135519900743)		0.00	19
33	Checkpoint inhibitor blockade and epigenetic reprogrammabili… (10.1177/2515135520904238)		0.00	4
34	Influenza vaccines: the potential benefits of cell-culture i… (10.1177/2515135520908121)		0.00	55
35	<i>Neisseria meningitidis</i>: analysis of pili and LPS in e… (10.1177/2515135520919195)		0.00	2
36	Development of vaccines against the sexually transmitted inf… (10.1177/2515135520923887)		0.00	13
37	Safety and immunogenicity of a seasonal trivalent inactivate… (10.1177/2515135520925336)		0.00	2
38	CAR T-cell immunotherapy of B-cell malignancy: the story so… (10.1177/2515135520927164)		0.00	40
39	Transgenic T-cell receptor immunotherapy for cancer: buildin… (10.1177/2515135520933509)		0.00	8
40	Evaluation of immunogenicity, safety and breakthrough follow… (10.1177/2515135520937216)		0.00	1
41	Profile of adverse events following immunization with measle… (10.1177/2515135520940131)		0.00	4
42	Delivery of adoptive cell therapy in the context of the heal… (10.1177/2515135520944355)		0.00	7
43	Optimising immunisation in children with 22q11 microdeletion (10.1177/2515135520957139)		0.00	4
44	Evaluation of two commercially-available <i>Salmonella</i> v… (10.1177/2515135520957760)		0.00	13
45	Efficiently cleaved HIV-1 envelopes: can they be important f… (10.1177/2515135520957763)		0.00	7
46	The digital immunization system of the future: imagining a p… (10.1177/2515135520967203)		0.00	21
47	Strategies for active and passive pediatric RSV immunization (10.1177/2515135520981516)		0.00	25
48	Dengvaxia: the world’s first vaccine for prevention of secon… (10.1177/25151355211015839)		0.00	53
49	Is it time to administer acellular pertussis vaccine to chil… (10.1177/25151355211015842)		0.00	2
50	Generating CAR T cells from tumor-infiltrating lymphocytes (10.1177/25151355211017119)		0.00	11